Pawel Sobczuk, Postdoctoral Fellow at Vall d’Hebron Institute of Oncology (VHIO), reshared a post on LinkedIn:
“Attending the ESMO Congress has never been more exciting than this year!
For the first time, the prospective clinical trial that I co-designed and co-run will be presented in the Proffered Paper sarcoma session by my dear friend and co-PI of the study, Katarzyna Kozak.
It’s the best award for almost 4 years of hard work of the whole team from Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie – Państwowy Instytut Badawczy. A study was also generously supported by Agencja Badań Medycznych and Immutep Limited.
Please join us on Sunday, October 19th, starting at 16.30 in Dortmund Auditorium to learn more about our results!”
More posts featuring Pawel Sobczuk on OncoDaily.